The strengths of our study include the number of cases tested with a total of 502 breast cancers including 133 IBC, a tumor rare but aggressive; to our knowledge, it is the first study analyzing specifically MARCKS protein expression in IBC and the largest one in breast cancer. The gene discussed is MARCKS; the disease is breast cancer.